Telix Pharmaceuticals Appoints Dr Colin Hayward as Chief Medical Officer

Melbourne (Australia) – 2nd June 2020. Telix Pharmaceuticals announces that Dr Colin Hayward has joined Telix’s executive leadership team in the role of Chief Medical Officer (CMO).

Telix Pharmaceuticals Limited is pleased to announce that Dr Colin Hayward has joined Telix’s executive leadership team in the role of Chief Medical Officer (CMO).

Dr Hayward joins Telix with over twenty years of global pharmaceutical, biotechnology and drug development experience and will lead the Company’s medical affairs, regulatory, clinical operations and pharmacovigilance activities on a global basis.

To read the full media release please click here.